Adoptive immunotherapy with bispecific antibodies: targeting through macrophages
- 1 January 1992
- journal article
- Published by Elsevier in Research in Immunology
- Vol. 143 (1) , 95-99
- https://doi.org/10.1016/0923-2494(92)80085-y
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effectsCancer Immunology, Immunotherapy, 1991
- Surface Phenotype Analysis of Human Monocyte to Macrophage MaturationJournal of Leukocyte Biology, 1990
- The functional properties of Fcγ RI, II and III on myeloid cells: A comparative study of killing of erythrocytes and tumor cells mediated through the different Fc receptorsMolecular Immunology, 1989
- Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.The Journal of Immunology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transferEuropean Journal of Cancer and Clinical Oncology, 1988
- Targeting of Cytotoxic Cells with Heterocrosslinked AntibodiesCancer Investigation, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- [24] Large-scale entrapment of drugs into resealed red blood cells using a continuous-flow dialysis systemPublished by Elsevier ,1987